The Global Antimicrobial Stewardship Accreditation Scheme is an ambitious initiative aimed at tackling AMR through accreditation and spread of good practice in antimicrobial stewardship. Supported by AMS experts from across the world the scheme provides advice and access to a wealth of open access education and training to enable facilities within any health economy to build robust and measurable antimicrobial stewardship services for their patients. To date client organisations from 15 countries across 4 continents have joined the scheme.

The UK Antimicrobial Registry, meanwhile, is a study that will capture real world data for recently licensed antibiotics to provide information on which patients benefit most from them and increase the evidence base on their effectiveness and safety. The Registry is currently being piloted across 4 UK hospitals and other hospitals are being encouraged to register for join the study when it is rolled out later this year.

Safely sheltered from the 26C heat of Dubai and surrounded by delegates from across the gulf states and thought leaders from the global infection community, both of Dr Sneddon’s updates were well received. Of particular interest was the opportunity to get involved with BSAC’s global AMS accreditation scheme, with Dr Sneddon calling for clinicians and sponsors to support this exciting initiative, to raise standards for AMS in health care facilities around the world.

If you would like to find out more about GAMSAS please contact us at: GAMSAS@bsac.org.uk